Tuesday, February 25, 2020

Latest:

Understanding fatty liver disease key to liver cancer prevention
Congratulations to the recipients of CPRIT grants for cancer research!
Reconstruction procedure gives breast cancer survivor new outlook
An unprecedented look at endometrial cancer
Eradication with vaccination? It’s worth a shot

Baylor College of Medicine Blog Network

Momentum
From The Labs
- About From the Labs
- Follow From The Labs on Twitter
PolicyWise
- About PolicyWise
- Follow @BCMEthics on Twitter
Progress Notes
- About Progress Notes
- Connect With Us
bcm.edu

endocrine resistant breast cancer

From The Labs

Becoming metastatic: how FOXA1 triggers metastatic behavior in breast cancer

January 16, 2020January 16, 2020 Ana Rodríguez 0 Comments endocrine resistant breast cancer, ER positive breast cancer, FOXA1, HIF-2a, Metastatic breast cancer, Research

About 75 percent of breast cancers have estrogen receptors, hence they are called estrogen receptor positive (ER+). Original ER+ breast

Baylor College of Medicine experts Drs. Pedro A. Piedra and Robert Atmar share facts you should know about the novel coronavirus outbreak.

From the Labs Image of the Month

From the Labs features an image of human breast epithelial cells. These cells can transform into carcinomas, which represent the vast majority of breast cancers.